Filing Details
- Accession Number:
- 0001181431-13-003229
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-15 16:14:14
- Reporting Period:
- 2013-01-11
- Filing Date:
- 2013-01-15
- Accepted Time:
- 2013-01-15 16:14:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 819050 | Vical Inc | VICL | Biological Products, (No Disgnostic Substances) (2836) | 930948554 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1305178 | Marie Jill Broadfoot | 10390 Pacific Center Court San Diego CA 92121 | Sr Vice President, Cfo, Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 Par Value | Acquisiton | 2013-01-11 | 27,060 | $0.01 | 234,935 | No | 4 | P | Direct | |
| Common Stock $.01 Par Value | Disposition | 2013-01-13 | 2,370 | $3.31 | 232,565 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2013-01-11 | 29,594 | $0.00 | 29,594 | $3.31 |
| Common Stock | Nonstatutory Stock Option (right to buy) | Acquisiton | 2013-01-11 | 123,515 | $0.00 | 123,515 | $3.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 791,594 | 2014-01-11 | 2023-01-10 | No | 4 | A | Direct |
| 915,109 | 2014-01-11 | 2023-01-10 | No | 4 | A | Direct |
Footnotes
- Shares were acquired pursuant to a restricted stock grant.
- This balance includes 89,810 of unvested restricted stock units.
- The right to exercise the above stock options generally vests 25% on the first anniversary date of the grant, with the remaining rights vesting quarterly over the remaining three years.
- Represents shares withheld for taxes upon the release of restricted stock granted on January 13, 2012.
Billionaire Hedge Funds
